Korro Bio, Inc.
KRRO
$13.28
-$0.01-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.60% | 16.09% | -136.06% | 13.99% | -18.07% |
| Total Depreciation and Amortization | -70.25% | -68.98% | -48.20% | 36.30% | 70.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.95% | 88.41% | 2,501.49% | 77.33% | 13.69% |
| Change in Net Operating Assets | -144.09% | 105.07% | -112.99% | -176.74% | -31.65% |
| Cash from Operations | 11.62% | 34.26% | -136.18% | -6.74% | -31.76% |
| Capital Expenditure | 73.57% | 82.35% | 94.21% | 96.41% | 97.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.07% | -197.93% | 1,242.42% | 200.92% | 88.43% |
| Cash from Investing | -58.42% | -198.35% | 639.46% | 160.39% | 88.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 51,186.05% | -59.23% | -82.42% | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -58,440.00% | 51,186.05% | -59.23% | -82.42% | -99.99% |
| Foreign Exchange rate Adjustments | 344.44% | -- | 1,975.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.77% | 369.04% | 75.02% | 66.16% | 38.23% |